Recent Updates
Recently added Catalysts
MDXG Positive Sentiment Score: 70/100

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Key Takeaway: MiMedx Group, Inc. (MDXG) will report its operating and financial results for the third quarter of 2024 on October 30, 2024, after market close. The company's management team will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will provide insights into the company's performance and ongoing commitment to innovation in the healthcare sector, particularly in wound care.

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is set to report financial results, indicating ongoing operations.
  • The conference call highlights transparency and communication with investors.
  • MIMEDX continues to position itself as a leader in wound care and healing solutions.

Full Press Release Details

MARIETTA, Ga., Oct. 14, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2024 after the market close on Wednesday, October 30, 2024. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13748866
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Frequently Asked Questions

When will MiMedx report its Q3 2024 financial results?

MiMedx will report its Q3 2024 results on October 30, 2024, after market close.

How can I access the MiMedx conference call?

U.S. investors can call 877-407-6184, and international investors can call 201-389-0877.

What is the Conference ID for the MiMedx call?

The Conference ID for the MiMedx call is 13748866.

Where can I find the MiMedx webcast replay?

The webcast replay will be available on the MiMedx website for about 30 days.

What is MiMedx's focus in healthcare?

MiMedx focuses on healing solutions for chronic wounds and surgical applications.

Last updated: Oct 14, 2024